🔗 Visit the ClinicalTrials.gov page for NCT01055392
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. | J Clin Psychiatry | 2014 | 2.13 |
| 2 | GSK-3 as potential target for therapeutic intervention in cancer. | Oncotarget | 2014 | 1.56 |
| 3 | Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia. | Expert Rev Neurother | 2011 | 0.91 |
| 4 | Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. | ACS Chem Neurosci | 2014 | 0.81 |
| 5 | The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. | J Prev Alzheimers Dis | 2014 | 0.78 |